Yahoo Poland Wyszukiwanie w Internecie

Search results

1. www.ncbi.nlm.nih.gov › pmc › articlesAdvances in the Treatment of Chronic Insomnia: A Narrative Review...

   www.ncbi.nlm.nih.gov › pmc › articles

   6 sie 2021 · While chronic insomnia is often considered a condition primarily related to impaired sleep, the disorder can also adversely affect domains of physical and mental health, quality of life, and daytime function, which highlights the importance of treating the multidimensional sleep disorder.

2. www.thelancet.com › journals › laneurImportant advances in sleep research in 2021 - The Lancet

   www.thelancet.com › journals › laneur

   Advances in sleep research in 2021 have brought about clinical developments for the next decade. Additionally, sleep telemedicine services have expanded rapidly, driven by the COVID-19 pandemic, to best serve patients with sleep disorders. 1 Here, we will explore some of the most impactful clinical studies from this field in 2021.

3. med.stanford.edu › news › all-newsEmmanuel Mignot wins Breakthrough Prize for discovering cause of...

   med.stanford.edu › news › all-news

   • Zapisane w pamięci cache

   22 wrz 2022 · The Stanford Medicine sleep researcher is honored for discovering the role of orexins in narcolepsy and paving the way to new sleep disorder therapies.

4. www.ncbi.nlm.nih.gov › pmc › articlesBehavioral and psychological treatments for chronic insomnia...

   www.ncbi.nlm.nih.gov › pmc › articles

   1 lut 2021 · The TF assessed whether sleep hygiene, as a single-component treatment, improved patient-reported critical outcomes: remission rate, responder rate, sleep quality, sleep latency and wake after sleep onset.

5. med.stanford.edu › news › all-newsStanford researcher shows once-nightly narcolepsy drug is safe...

   med.stanford.edu › news › all-news

   • Zapisane w pamięci cache

   8 wrz 2021 · Sodium oxybate is effective at treating multiple narcolepsy symptoms, including disrupted nighttime sleep. But because its half-life is approximately 30 minutes to 1 hour, a second dose is required 2 ½ to 4 hours after the first dose.

6. www.medcentral.com › behavioral-mental › sleep-disordersSleep Medications: What’s New for Insomnia, Sleep Apnea, and More

   www.medcentral.com › behavioral-mental › sleep-disorders

   • Zapisane w pamięci cache

   13 sie 2024 · Sleep medicine currently relies heavily on stimulants to treat excessive sleepiness. Armodafinil (Nuvigil) and modafinil (Provigil) are stimulants US Food and Drug Administration (FDA) approved to treat OSA and narcolepsy.

7. www.mayoclinic.org › diseases-conditions › sleep-disordersSleep disorders - Diagnosis and treatment - Mayo Clinic

   www.mayoclinic.org › diseases-conditions › sleep-disorders

   • Zapisane w pamięci cache

   10 wrz 2024 · Medicines and supplements may help treat some sleep disorders. Clinical trials. Explore Mayo Clinic studies testing new treatments, interventions and tests as a means to prevent, detect, treat or manage this condition.